The SSX family of cancer-testis antigens as target proteins for tumor therapy

Clinical and Developmental Immunology

Volumn 2010, Issue , 2010, Pages

  Smith, Heath A ^a   McNeel, Douglas G ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER TESTIS ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TUMOR ANTIGEN; CANCER VACCINE; REPRESSOR PROTEIN; SYNOVIAL SARCOMA X BREAKPOINT PROTEINS; TUMOR PROTEIN;

ANTIGEN EXPRESSION; CANCER THERAPY; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; HELA CELL; HISTOLOGY; HUMAN; HUMORAL IMMUNITY; IMMUNOLOGY; IMMUNOTHERAPY; MESENCHYMAL STEM CELL; MULTIPLE CANCER; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN TARGETING; REVIEW; SOUTHERN BLOTTING; SYNOVIAL SARCOMA; TESTIS; X CHROMOSOME; YEAST ARTIFICIAL CHROMOSOME; CYTOTOXICITY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; METHODOLOGY; NEOPLASM; PROGNOSIS;

ANTIGENS, NEOPLASM; CANCER VACCINES; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOTHERAPY; MALE; NEOPLASM PROTEINS; NEOPLASMS; PROGNOSIS; REPRESSOR PROTEINS;

EID: 78349289653     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2010/150591     Document Type: Review

References (124)

1. Ghafouri-Fard S., Modarressi M.-H., Cancer-testis antigens: potential targets for cancer immunotherapy Archives of Iranian Medicine 2009 12 4 395 404
2. Caballero O. L., Chen Y.-T., Cancer/testis (CT) antigens: potential targets for immunotherapy Cancer Science 2009 100 11 2014 2021
3. Mueller J. L., Mahadevaiah S. K., Park P. J., Warburton P. E., Page D. C., Turner J. M. A., The mouse X chromosome is enriched for multicopy testis genes showing postmeiotic expression Nature Genetics 2008 40 6 794 799
4. Ross M. T., Grafham D. V., Coffey A. J., Scherer S., McLay K., Muzny D., Platzer M., Howell G. R., Burrows C., Bird C. P., Prankish A., Lovell F. L., Howe K. L., Ashurst J. L., Fulton R. S., Sudbrak R., Wen G., Jones M. C., Hurles M. E., Andrews T. D., Scott C. E., Searle S., Ramser J., Whittaker A., Deadman R., Carter N. P., Hunt S. E., Chen R., Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M. L., Richards S., Scott G., Steffen D., Sodergren E., Wheeler D. A., Worley K. C., Alnscough R., Ambrose K. D., Ansari-Lari M. A., Aradhya S., Ashwell R. I. S., Babbage A. K., Bagguley C. L., Ballabio A., Banerjee R., Barker G. E., Barlow K. F., Barrett I. P., Bates K. N., Beare D. M., Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A. M., Brown A. J., Brown M. J., Bonnin D., Bruford E. A., Buhay C., Burch P., Burford D., Burgess J., Burrill W., Burton J., Bye J. M., Carder C., Carrel L., Chako J., Chapman J. C., Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C., Ciccodicola A., Clark S. Y., Clarke G., Clee C. M., Clegg S., Clerc-Blankenburg K., Clifford K., Cobley V., Cole C. G., Conquer J. S., Corby N., Connor R. E., David R., Davies J., Davis C., Davis J., Delgado O., DeShazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K. J., Dutta I., Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K. L., Faulkner L., Francis F., Frankland J., Fraser A. E., Galgoczy P., Gilbert J., Gill R., Glckner G., Gregory S. G., Gribble S., Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E. A., Hawes A., Heath P. D., Heitmann K., Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P. J., Huckle E. J., Hume J., Hunt P. J., Hunt A. R., Isherwood J., Jacob L., Johnson D., Jones S., De Jong P. J., Joseph S. S., Keenan S., Kelly S., Kershaw J. K., Khan Z., Kloschis P., Klages S., Knights A. J., Kosiura A., Kovar-Smith C., Laird G. K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W., Lloyd C., Lloyd D. M., Loulseged H., Loveland J. E., Lovell J. D., Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L. H., McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S., Miner G., Mistry S. L., Morgan M., Morris S., Mller I., Mullikin J. C., Nguyen N., Nordsiek G., Nyakatura G., O'Dell C. N., Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A. V., Pearson D. M., Pelan S. E., Perez L., Porter K. M., Ramsey Y., Reichwald K., Rhodes S., Ridler K. A., Schlessinger D., Schueler M. G., Sehra H. K., Shaw-Smith C., Shen H., Sheridan E. M., Shownkeen R., Skuce C. D., Smith M. L., Sotheran E. C., Steingruber H. E., Steward C. A., Storey R., Swann R. M., Swarbreck D., Tabor P. E., Taudien S., Taylor T., Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A. C., D'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q., Warren J., Warry G. L., Wei X., West A., Whitehead S. L., Whiteley M. N., Wilkinson J. E., Willey D. L., Williams G., Williams L., Williamson A., Williamson H., Wilming L., Woodmansey R. L., Wray P. W., Yen J., Zhang J., Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A., Lehrach H., Meindl A., Minx P. J., Hillier L. W., Willard H. F., Wilson R. K., Waterston R. H., Rice C. M., Vaudin M., Coulson A., Nelson D. L., Weinstock G., Sulston J. E., Durbin R., Hubbard T., Gibbs R. A., Beck S., Rogers J., Bentley D. R., The DNA sequence of the human X chromosome Nature 2005 434 7031 325 337
5. Zendman A. J. W., Ruiter D. J., Van Muijen G. N. P., Cancer/testis- associated genes: identification, expression profile, and putative function Journal of Cellular Physiology 2003 194 3 272 288
6. Meinhardt A., Hedger M. P., Immunological, paracrine and endocrine aspects of testicular immune privilege. Molecular and Cellular Endocrinology. In press
7. Fijak M., Meinhardt A., The testis in immune privilege Immunological Reviews 2006 213 1 66 81
8. Derbinski J., Schulte A., Kyewski B., Klein L., Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self Nature Immunology 2001 2 11 1032 1039
9. Jger E., Karbach J., Gnjatic S., Neumann A., Bender A., Valmori D., Ayyoub M., Ritter E., Ritter G., Jger D., Panicali D., Hoffman E., Pan L., Oettgen H., Old L. J., Knuth A., Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients Proceedings of the National Academy of Sciences of the United States of America 2006 103 39 14453 14458
10. Marchand M., Van Baren N., Weynants P., Brichard V., Drno B., Tessier M.-H., Rankin E., Parmiani G., Arienti F., Humblet Y., Bourlond A., Vanwijck R., Linard D., Beauduin M., Dietrich P.-Y., Russo V., Kerger J., Masucci G., Jger E., De Greve J., Atzpodien J., Brasseur F., Coulie P. G., Van Der Bruggen P., Boon T., Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1 International Journal of Cancer 1999 80 2 219 230
11. Cluff C. W., Monophosphoryl lipid A (MPL) as an adjuvant for anti-cancer vaccines: clinical results Advances in Experimental Medicine and Biology 2009 667 111 123
12. Disis M. L., Cheever M. A., HER-2/neu oncogenic protein: issues in vaccine development Critical Reviews in Immunology 1998 18 1-2 37 45
13. Engelhard V. H., Bullock T. N. J., Colella T. A., Sheasley S. L., Mullins D. W., Antigens derived from melanocyte differentiation proteins: self-tolerance, autoimmunity, and use for cancer immunotherapy Immunological Reviews 2002 188 136 146
14. Cheever M. A., Allison J. P., Ferris A. S., Finn O. J., Hastings B. M., Hecht T. T., Mellman I., Prindiville S. A., Viner J. L., Weiner L. M., Matrisian L. M., The prioritization of cancer antigens: a National Cancer Institute pilot project for the acceleration of translational research Clinical Cancer Research 2009 15 17 5323 5337
15. Inagaki H., Nagasaka T., Otsuka T., Sugiura E., Nakashima N., Eimoto T., Association of SYT-SSX fusion types with proliferative activity and prognosis in synovial sarcoma Modern Pathology 2000 13 5 482 488
16. Smith S., Reeves B. R., Wong L., Fisher C., A consistent chromosome translocation in synovial sarcoma Cancer Genetics and Cytogenetics 1987 26 1 179 180
17. Turc-Carel C., Dal Cin P., Limon J., Involvement of chromosome X in primary cytogenetic change in human neoplasia: nonrandom translocation in synovial sarcoma Proceedings of the National Academy of Sciences of the United States of America 1987 84 7 1981 1985
18. Wang-Wuu S., Soukup S. W., Lange B. J., Another synovial sarcoma with t(X;18) Cancer Genetics and Cytogenetics 1987 29 1 179 181
19. Limon J., Mrozek K., Mandahl N., Nedoszytko B., Verhest A., Rys J., Niezabitowski A., Babinska M., Nosek H., Ochalek T., Kopacz A., Willen H., Rydholm A., Heim S., Mitelman F., Cytogenetics of synovial sarcoma: presentation of ten new cases and review of the literature Genes Chromosomes and Cancer 1991 3 5 338 345
20. Clark J., Rocques P. J., Crew A. J., Gill S., Shipley J., Chan A. M.-L., Gusterson B. A., Cooper C. S., Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma Nature Genetics 1994 7 4 502 508
21. Crew A. J., Clark J., Fisher C., Gill S., Grimer R., Chand A., Shipley J., Gusterson B. A., Cooper C. S., Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma EMBO Journal 1995 14 10 2333 2340
22. Treci., Sahin U., Schobert I., Koslowski M., Schmitt H., Schild H.-J., Stenner F., Seitz G., Rammensee H.-G., Pfreundschuh M., The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40 Cancer Research 1996 56 20 4766 4772
23. Shipley J. M., Clark J., Crew A. J., Birdsall S., Rocques P. J., Gill S., Chelly J., Monaco A. P., Abe S., Gusterson B. A., Cooper C. S., The t(X;18)(p11.2;q11.2) translocation found in human synovial sarcomas involves two distinct loci on the X chromosome Oncogene 1994 9 5 1447 1453
24. Sonobe H., Manabe Y., Furihata M., Iwata J., Oka T., Ohtsuki Y., Mizobuchi H., Yamamoto H., Kumano O., Abe S., Establishment and characterization of a new human synovial sarcoma cell line, HS-SY-II Laboratory Investigation 1992 67 4 498 505
25. Chand A., Clark J., Cooper C. S., Craig I. W., Long-range organization of reiterated sequences, including the SSX1 cDNA, at the OATL1 cluster in Xp11.23 Genomics 1995 30 3 545 552
26. de Leeuw B., Balemans M., Geurts van Kessel A., A novel Kruppel-associated box containing the SSX gene (SSX3) on the human X chromosome is not implicated in t(X;18)-positive synovial sarcomas Cytogenetics and Cell Genetics 1996 73 3 179 183
27. Gure A. O., Treci., Sahin U., Tsang S., Scanlan M. J., Jger E., Knuth A., Pfreundschuh M., Old L. J., Chen Y.-T., SSX: a multigene family with several members transcribed in normal testis and human cancer International Journal of Cancer 1997 72 6 965 971
28. dos Santos N. R., de Bruijn D. R. H., van Kessel A. G., Molecular mechanisms underlying human synovial sarcoma development Genes Chromosomes and Cancer 2001 30 1 1 14
29. Gre A. O., Wei I. J., Old L. J., Chen Y.-T., The SSX gene family: characterization of 9 complete genes International Journal of Cancer 2002 101 5 448 453
30. Chen Y.-T., Alpen B., Ono T., Gure A. O., Scanlan M. A., Biggs W. H. III, Arden K., Nakayama E., Old L. J., Identification and characterization of mouse SSX genes: a multigene family on the X chromosome with restricted cancer/testis expression Genomics 2003 82 6 628 636
31. Margolin J. F., Friedman J. R., Meyer W. K.-H., Vissing H., Thiesen H. J., Rauscher F. J. III, Kruppel-associated boxes are potent transcriptional repression domains Proceedings of the National Academy of Sciences of the United States of America 1994 91 10 4509 4513
32. Witzgall R., O'Leary E., Leaf A., Onaldi D., Bonventre J. V., The Kruppel-associated box-A (KRAB-A) domain of zinc finger proteins mediates transcriptional repression Proceedings of the National Academy of Sciences of the United States of America 1994 91 10 4514 4518
33. dos Santos N. R., de Bruijn D. R. H., Balemans M., Janssen B., Grtner F., Lopes J. M., de Leeuw B., van Kessel A. G., Nuclear localization of SYT, SSX and the synovial sarcoma-associated SYT-SSX fusion proteins Human Molecular Genetics 1997 6 9 1549 1558
34. Brett D., Whitehouse S., Antonson P., Shipley J., Cooper C., Goodwin G., The SYT protein involved in the t(X;18) synovial sarcoma translocation is a transcriptional activator localised in nuclear bodies Human Molecular Genetics 1997 6 9 1559 1564
35. Lim F. L., Soulez M., Koczan D., Thiesen H.-J., Knight J. C., A KRAB-related domain and a novel transcription repression domain in proteins encoded by SSX genes that are disrupted in human sarcomas Oncogene 1998 17 15 2013 2018
36. Vissing H., Meyer W. K.-H., Aagaard L., Tommerup N., Thiesen H.-J., Repression of transcriptional activity by heterologous KRAB domains present in zinc finger proteins FEBS Letters 1995 369 2-3 153 157
37. dos Santos N. R., de Bruijn D. R. H., Kater-Baats E., Otte A. P., van Kessel A. G., Delineation of the protein domains responsible for SYT, SSX, and SYT-SSX nuclear localization Experimental Cell Research 2000 256 1 192 202
38. Soulez M., Saurin A. J., Freemont P. S., Knight J. C., SSX and the synovial-sarcoma-specific chimaeric protein SYT-SSX co-localize with the human Polycomb group complex Oncogene 1999 18 17 2739 2746
39. Saurin A. J., Shiels C., Williamson J., Satijn D. P. E., Otte A. P., Sheer D., Freemont P. S., The human polycomb group complex associates with pericentromeric heterochromatin to form a novel nuclear domain Journal of Cell Biology 1998 142 4 887 898
40. Kato H., Tjernberg A., Zhang W., Krutchinsky A. N., An W., Takeuchi T., Ohtsuki Y., Sugano S., de Bruijn D. R., Chait B. T., Roeder R. G., SYT associates with human SNF/SWI complexes and the C-terminal region of its fusion partner SSX1 targets histones Journal of Biological Chemistry 2002 277 7 5498 5505
41. Schumacher A., Magnuson T., Murine Polycomb- and trithorax-group genes regulate homeotic pathways and beyond Trends in Genetics 1997 13 5 167 170
42. Core N., Bel S., Gaunt S. J., Aurrand-Lions M., Pearce J., Fisher A., Djabali M., Altered cellular proliferation and mesoderm patterning in Polycomb-M33-deficient mice Development 1997 124 3 721 729
43. Haupt Y., Alexander W. S., Barri G., Klinken S. P., Adams J. M., Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in E -myc transgenic mice Cell 1991 65 5 753 763
44. Bienz M., Muller J., Transcriptional silencing of homeotic genes in Drosophila BioEssays 1995 17 9 775 784
45. Pirrotta V., Polycombing the genome: PcG, trxG and chromatin silencing Cell 1998 93 3 333 336
46. Paro R., Imprinting a determined state into the chromatin of Drosophila Trends in Genetics 1990 6 12 416 421
47. de Bruijn D. R. H., dos Santos N. R., Kater-Baats E., Thijssen J., Van Den Berk L., Stap J., Balemans M., Schepens M., Merkx G., van Kessel A. G., The cancer-related protein SSX2 interacts with the human homologue of a Ras-like GTPase interactor, RAB3IP, and a novel nuclear protein, SSX2IP Genes Chromosomes and Cancer 2002 34 3 285 298
48. Yoshida M., Yagi T., Furuta Y., Takayanagi K., Kominami R., Takeda N., Tokunaga T., Chiba J., Ikawa Y., Aizawa S., A new strategy of gene trapping in ES cells using 3'RACE Transgenic Research 1995 4 4 277 287
49. Cooper P. R., Nowak N. J., Higgins M. J., Church D. M., Shows T. B., Transcript mapping of the human chromosome 11q12-q13.1 gene-rich region identifies several newly described conserved genes Genomics 1998 49 3 419 429
50. Mandahl N., Heim S., Arheden K., Rydholm A., Willen H., Mitelman F., Three major cytogenic subgroups can be identified among chromosomally abnormal solitary lipomas Human Genetics 1988 79 3 203 208
51. Forus A., Florenes V. A., Maelandsmo G. M., Meltzer P. S., Fodstad O., Myklebost O., Mapping of amplification units in the q13-14 region of chromosome-12 in human sarcomassome amplica do not include MDM2 Cell Growth and Differentiation 1993 4 12 1065 1070
52. Knuutila S., Aalto Y., Autio K., Bjrkqvist A.-M., El-Rifai W., Hemmer S., Huhta T., Kettunen E., Kiuru-Kuhlefelt S., Larramendy M. L., Lushnikova T., Monni O., Pere H., Tapper J., Tarkkanen M., Varis A., Wasenius V.-M., Wolf M., Zhu Y., DNA copy number losses in human neoplasms American Journal of Pathology 1999 155 3 683 694 (Pubitemid 29426813)
53. Cigudosa J. C., Parsa N. Z., Louie D. C., Filippa D. A., Jhanwar S. C., Johansson B., Mitelman F., Chaganti R. S. K., Cytogenetic analysis of 363 consecutively ascertained diffuse large B-cell lymphomas Genes Chromosomes and Cancer 1999 25 2 123 133
54. Knuutila S., Bjorkqvist A.-M., Autio K., Tarkkanen M., Wolf M., Monni O., Szymanska J., Larramendy M. L., Tapper J., Pere H., El-Rifai W., Hemmer S., Wasenius V.-M., Vidgren V., Zhu Y., DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies American Journal of Pathology 1998 152 5 1107 1123 (Pubitemid 28221862)
55. Breslin A., Denniss F. A. K., Guinn B.-A., SSX2IP: an emerging role in cancer Biochemical and Biophysical Research Communications 2007 363 3 462 465
56. Guinn B.-A., Bland E. A., Lodi U., Liggins A. P., Tobal K., Petters S., Wells J. W., Banham A. H., Mufti G. J., Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemia Biochemical and Biophysical Research Communications 2005 335 4 1293 1304
57. Denniss F. A. K., Breslin A., Ingram W., Hardwick N. R., Mufti G. J., Guinn B.-A., The leukaemia-associated antigen, SSX2IP, is expressed during mitosis on the surface of myeloid leukaemia cells British Journal of Haematology 2007 138 5 668 669
58. Guinn B.-A., Bullinger L., Thomas N. S. B., Mills K. I., Greiner J., SSX2IP expression in acute myeloid leukaemia: an association with mitotic spindle failure in t(8;21), and cell cycle in t(15;17) patients British Journal of Haematology 2008 140 2 250 251
59. de Bruijn D. R. H., van Dijk A. H. A., Willemse M. P., van Kessel A. G., The C terminus of the synovial sarcoma-associated SSX proteins interacts with the LIM homeobox protein LHX4 Oncogene 2008 27 5 653 662
60. Wu H.-K., Heng H. H. Q., Siderovski D. P., Dong W.-F., Okuno Y., Shi X.-M., Tsui L.-C., Minden M. D., Identification of a human LIM-Hox gene, hLH-2, aberrantly expressed in chronic myelogenous leukaemia and located on 9q33-34.1 Oncogene 1996 12 6 1205 1212
61. Dong W. F., Heng H. H., Lowsky R., Cloning, expression, and chromosomal localization to 11p12-13 of a human LIM/HOMEOBOX gene, hLim-1 DNA and Cell Biology 1997 16 6 671 678
62. Wu H.-K., Minden M. D., Transcriptional activation of human LIM-HOX gene, hLH-2, in chronic myelogenous leukemia is due to a cis-acting effect of Bcr-Abl Biochemical and Biophysical Research Communications 1997 233 3 806 812
63. Kawamata N., Sakajiri S., Sugimoto K.-J., Isobe Y., Kobayashi H., Oshimi K., A novel chromosomal translocation t(1;14)(q25;q32) in pre-B acute lymphoblastic leukemia involves the LIM homeodomain protein gene, Lhx4 Oncogene 2002 21 32 4983 4991
64. Yamaguchi M., Yamamoto K., Miura O., Aberrant expression of the LHX4 LIM-homeobox gene caused by t(1;14)(q25;q32) in chronic myelogenous leukemia in biphenotypic blast crisis Genes Chromosomes and Cancer 2003 38 3 269 273
65. Roberson M. S., Schoderbek W. E., Tremml G., Maurer R. A., Activation of the glycoprotein hormone -subunit promoter by a LIM-homeodomain transcription factor Molecular and Cellular Biology 1994 14 5 2985 2993
66. Cronwright G., Le Blanc K., Gtherstrm C., Darcy P., Ehnman M., Brodin B., Cancer/testis antigen expression in human mesenchymal stem cells: down-regulation of SSX impairs cell migration and matrix metalloproteinase 2 expression Cancer Research 2005 65 6 2207 2215
67. de Leeuw B., Balemans M., Olde Weghuis D., Guerts van Kessel G., Identification of two alternative fusion genes, SYT-SSX1 and SYT-SSX2, in t(X;18)(p11.2;q11.2)-positive synovial sarcomas Human Molecular Genetics 1995 4 6 1097 1099
68. dos Santos N. R., Torensma R., De Vries T. J., Schreurs M. W. J., de Bruijn D. R. H., Kater-Baats E., Ruiter D. J., Adema G. J., Van Muijen G. N. P., van Kessel A. G., Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines Cancer Research 2000 60 6 1654 1662
69. Del Mazo J., Prantera G., Torres M., Ferraro M., DNA methylation changes during mouse spermatogenesis Chromosome Research 1994 2 2 147 152
70. Martorell M. R., Navarro J., Mrquez C., Egozcue J., Benet J., Hypomethylation of human sperm pronuclear chromosomes Cytogenetics and Cell Genetics 1997 76 3-4 123 127
71. Gartler S. M., Goldman M. A., Reactivation of inactive X-linked genes Developmental Genetics 1994 15 6 504 514
72. Jones P. A., Gonzalgo M. L., Altered DNA methylation and genome instability: a new pathway to cancer? Proceedings of the National Academy of Sciences of the United States of America 1997 94 6 2103 2105
73. Held G., Neumann F., Sturm C., Kaestner L., Dauth N., de Bruijn D. R., Renner C., Lipp P., Pfreundschuh M., Differential presentation of tumor antigen-derived epitopes by MHC-class I and antigen-positive tumor cells International Journal of Cancer 2008 123 8 1841 1847
74. Dubovsky J. A., McNeel D. G., Inducible expression of a prostate cancer-testis antigen, SSX-2, following treatment with a DNA methylation inhibitor Prostate 2007 67 16 1781 1790
75. Skytting B., Nilsson G., Brodin B., Xie Y., Lundeberg J., Uhlen M., Larsson O., A novel fusion gene, SYT-SSX4, in synovial sarcoma Journal of the National Cancer Institute 1999 91 11 974 975
76. Treci., Chen Y.-T., Sahin U., Gre A. O., Zwick C., Villena C., Tsang S., Seitz G., Old L. J., Pfreundschuh M., Expression of SSX genes in human tumors International Journal of Cancer 1998 77 1 19 23
77. Mischo A., Kubuschok B., Ertan K., Preuss K.-D., Romeike B., Regitz E., Schormann C., de Bruijn D., Wadle A., Neumann F., Schmidt W., Renner C., Pfreundschuh M., Prospective study on the expression of cancer testis genes and antibody responses in 100 consecutive patients with primary breast cancer International Journal of Cancer 2006 118 3 696 703
78. Mashino K., Sadanaga N., Tanaka F., Yamaguchi H., Nagashima H., Inoue H., Sugimachi K., Mori M., Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas British Journal of Cancer 2001 85 5 713 720
79. Utsunomiya T., Inoue H., Tanaka F., Yamaguchi H., Ohta M., Okamoto M., Mimori K., Mori M., Expression of cancer-testis antigen (CTA) genes in intrahepatic cholangiocarcinoma Annals of Surgical Oncology 2004 11 10 934 940
80. Li M., Yuan Y.-H., Han Y., Liu Y.-X., Yan L., Wang Y., Gu J., Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue Clinical Cancer Research 2005 11 5 1809 1814
81. Chen C.-H., Chen G.-J., Lee H.-S., Huang G.-T., Yang P.-M., Tsai L.-J., Chen D.-S., Sheu J.-C., Expressions of cancer-testis antigens in human hepatocellular carcinomas Cancer Letters 2001 164 2 189 195
82. Colleoni G. W. B., Capodieci P., Tickoo S., Cossman J., Filippa D. A., Ladanyi M., Expression of SSX genes in the neoplastic cells of Hodgkin's lymphoma Human Pathology 2002 33 5 496 502
83. Niemeyer P., Treci O., Eberle T., Graf N., Pfreundschuh M., Sahin U., Expression of serologically identified tumor antigens in acute leukemias Leukemia Research 2003 27 7 655 660
84. Wang Y., Liang Z., Yuan Y. H., Han Y., Liu Y. X., Liu N., Chen Y. T., Ritter G., Old L. J., Zhang L. J., Expression of multiple cancer-testis antigen genes in non-small cell lung cancer treated by chemotherapy prior surgery Zhonghua Yi Xue Za Zhi 2004 84 6 464 468
85. Sigalotti L., Coral S., Altomonte M., Natali L., Gaudino G., Cacciotti P., Libener R., Colizzi F., Vianale G., Martini F., Tognon M., Jungbluth A., Cebon J., Maraskovsky E., Mutti L., Maio M., Cancer testis antigens expression in mesothelioma: role of DNA methylation and bioimmunotherapeutic implications British Journal of Cancer 2002 86 6 979 982
86. Taylor B. J., Reiman T., Pittman J. A., Keats J. J., de Bruijn D. R. H., Mant M. J., Belch A. R., Pilarski L. M., SSX cancer testis antigens are expressed in most multiple myeloma patients: co-expression of SSX1, 2, 4, and 5 correlates with adverse prognosis and high frequencies of SSX-positive PCs Journal of Immunotherapy 2005 28 6 564 575
87. Chi S. N., Cheung N.-K. V., Cheung I. Y., Expression of SSX-2 and SSX-4 genes in neuroblastoma International Journal of Biological Markers 2002 17 4 219 223
88. Xie X., Wacker H.-H., Huang S., Regitz E., Preuss K.-D., Romeike B., Parwaresch R., Tiemann M., Pfreundschuh M., Differential expression of cancer testis genes in histological subtypes of non-Hodgkin's lymphomas Clinical Cancer Research 2003 9 1 167 173
89. Naka N., Araki N., Nakanishi H., Itoh K., Mano M., Ishiguro S., de Bruijn D. R. H., Myoui A., Ueda T., Yoshikawa H., Expression of SSX genes in human osteosarcomas International Journal of Cancer 2002 98 4 640 642
90. Kubuschok B., Xie X., Jesnowski R., Preuss K.-D., Romeike B. F. M., Neumann F., Regitz E., Pistorius G., Schilling M., Scheunemann P., Izbicki J. R., Lhr J.-M., Pfreundschuh M., Expression of cancer testis antigens in pancreatic carcinoma cell lines, pancreatic adenocarcinoma and chronic pancreatitis International Journal of Cancer 2004 109 4 568 575
91. Schmitz-Winnenthal F. H., Galindo-Escobedo L. V., Rimoldi D., Geng W., Romero P., Koch M., Weitz J., Krempien R., Niethammer A. G., Beckhove P., Buchler M. W., Z'graggen K., Potential target antigens for immunotherapy in human pancreatic cancer Cancer Letters 2007 252 2 290 298
92. Sahin U., Koslowski M., Tureci O., Eberle T., Zwick C., Romeike B., Moringlane J.-R., Schwechheimer K., Feiden W., Pfreundschuh M., Expression of cancer testis genes in human brain tumors Clinical Cancer Research 2000 6 10 3916 3922
93. Naka N., Joyama S., Tsukamoto Y., Yoshioka K., Hashimoto N., Ujiiye T., Hayashi T., Kawase M., Mano M., Ishiguro S., Myoui A., Ueda T., Yoshikawa H., Araki N., Itoh K., Quantification of SSX mRNA expression in human bone and soft tissue tumors using nucleic acid sequence-based amplification Journal of Molecular Diagnostics 2005 7 2 187 197
94. Sigalotti L., Covre A., Zabierowski S., Himes B., Colizzi F., Natali P. G., Herlyn M., Maio M., Cancer testis antigens in human melanoma stem cells: expression, distribution, and methylation status Journal of Cellular Physiology 2008 215 2 287 291
95. Fradet Y., Picard V., Bergeron A., LaRue H., Cancer-testis antigen expression in bladder cancer Progres en Urologie 2006 16 4 421 428
96. Sigalotti L., Fratta E., Coral S., Tanzarella S., Danielli R., Colizzi F., Fonsatti E., Traversari C., Altomonte M., Maio M., Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2′-deoxycytidine Cancer Research 2004 64 24 9167 9171
97. Sahin U., Treci., Schmitt H., Cochlovius B., Johannes T., Schmits R., Stenner F., Luo G., Schobert I., Pfreundschun M., Human neoplasms elicit multiple specific immune responses in the autologous host Proceedings of the National Academy of Sciences of the United States of America 1995 92 25 11810 11813
98. Stockert E., Jger E., Chen Y.-T., Scanlan M. J., Gout I., Karbach J., Arand M., Knuth A., Old L. J., A survey of the humoral immune response of cancer patients to a panel of human tumor antigens Journal of Experimental Medicine 1998 187 8 1349 1354
99. Scanlan M. J., Welt S., Gordon C. M., Chen Y.-T., Gure A. O., Stockert E., Jungbluth A. A., Ritter G., Jger D., Jger E., Knuth A., Old L. J., Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets Cancer Research 2002 62 14 4041 4047
100. Hasegawa K., Koizumi F., Noguchi Y., Hongo A., Mizutani Y., Kodama J., Hiramatsu Y., Nakayama E., SSX expression in gynecological cancers and antibody response in patients Cancer Immunity 2004 4, article 16
101. Taylor D. D., Gercel-Taylor C., Parker L. P., Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer Gynecologic Oncology 2009 115 1 112 120
102. Jger D., Stockert E., Scanlan M. J., Gre A. O., Jger E., Knuth A., Old L. J., Chen Y.-T., Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene Cancer Research 1999 59 24 6197 6204
103. Valmori D., Qian F., Ayyoub M., Renner C., Merlo A., Gjnatic S., Stockert E., Driscoll D., Lele S., Old L. J., Odunsi K., Expression of synovial sarcoma X (SSX) antigens in epithelial ovarian cancer and identification of SSX-4 epitopes recognized by CD4+ T cells Clinical Cancer Research 2006 12 2 398 404
104. Ayyoub M., Stevanovic S., Sahin U., Guillaume P., Servis C., Rimoldi D., Valmori D., Romero P., Cerottini J.-C., Rammensee H.-G., Pfreundschuh M., Speiser D., Lvy F., Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanoma Journal of Immunology 2002 168 4 1717 1722
105. Ayyoub M., Rimoldi D., Guillaume P., Romero P., Cerottini J.-C., Valmori D., Speiser D., Tumor-reactive, SSX-2-specific CD8+ T cells are selectively expanded during immune responses to antigen-expressing tumors in melanoma patients Cancer Research 2003 63 17 5601 5606
106. Ayyoub M., Brehm M., Metthez G., Talbot S., Dutoit V., Taub R. N., Keohan M. L., Gure A. O., Chen Y. T., Williamson B., Jungbluth A. A., Old L. J., Hesdorffer C. S., Valmori D., SSX antigens as tumor vaccine targets in human sarcoma Cancer Immunity 2003 3, article 13
107. He Y., Mao L., Lin Z., Deng Y., Tang Y., Jiang M., Li W., Jia Z., Wang J., Ni B., Wu Y., Identification of a common HLA-A0201-restricted epitope among SSX family members by mimicking altered peptide ligands strategy Molecular Immunology 2008 45 9 2455 2464
108. Wagner C., Neumann F., Kubuschok B., Regitz E., Mischo A., Stevanovic S., Friedrich M., Schmidt W., Rammensee H. G., Pfreundschuh M., Identification of an HLA-A02 restricted immunogenic peptide derived from the cancer testis antigen HOM-MEL-40/SSX2 Cancer Immunity 2003 3, article 18
109. Rentzsch C., Kayser S., Stumm S., Watermann I., Walter S., Stevanovic S., Wallwiener D., Gckel B., Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells Clinical Cancer Research 2003 9 12 4376 4386
110. Ayyoub M., Hesdorffer C. S., Metthez G., Stevaovic S., Ritter G., Che Y.-T., Old L. J., Speiser D., Cerott J.-C. II, Valmori D., Identification of an SSX-2 epitope presented by dendritic cells to circulating autologous CD4+ T cells Journal of Immunology 2004 172 11 7206 7211
111. Ayyoub M., Merlo A., Hesdorffer C. S., Speiser D., Rimoldi D., Cerottini J.-C., Ritter G., Chen Y.-T., Old L. J., Stevanovic S., Valmori D., Distinct but overlapping T helper epitopes in the 37-58 region of SSX-2 Clinical Immunology 2005 114 1 70 78
112. Ayyoub M., Hesdorffer C. S., Montes M., Merlo A., Speiser D., Rimoldi D., Cerottini J.-C., Ritter G., Scanlan M., Old L. J., Valmori D., An immunodominant SSX-2-derived epitope recognized by CD4+ T cells in association with HLA-DR Journal of Clinical Investigation 2004 113 8 1225 1233
113. Neumann F., Wagner C., Stevanovic S., Kubuschok B., Schormann C., Mischo A., Ertan K., Schmidt W., Pfreundschuh M., Identification of an HLA-DR-restricted peptide epitope with a promiscuous binding pattern derived from the cancer testis antigen HOM-MEL-40/SSX2 International Journal of Cancer 2004 112 4 661 668
114. Godefroy E., Wang Y., Souleimanian N. E., Scotto L., Stevanovic S., Chen Y.-T., Valmori D., Ayyoub M., Assessment of CD4+ T cells specific for the tumor antigen SSX-1 in cancer-free individuals Cancer Immunology, Immunotherapy 2007 56 8 1183 1192
115. Ayyoub M., Merlo A., Hesdorffer C. S., Rimoldi D., Speiser D., Cerottini J.-C., Chen Y.-T., Old L. J., Stevanovic S., Valmori D., CD4+ T cell responses to SSX-4 in melanoma patients Journal of Immunology 2005 174 8 5092 5099
116. Bricard G., Bouzourene H., Martinet O., Rimoldi D., Halkic N., Gillet M., Chaubert P., MacDonald H. R., Romero P., Cerottini J.-C., Speiser D. E., Naturally acquired MAGE-A10- and SSX-2-specific CD8+ T cell responses in patients with hepatocellular carcinoma Journal of Immunology 2005 174 3 1709 1716
117. Rubio-Godoy V., Ayyoub M., Dutoit V., Servis C., Schink A., Rimoldi D., Romero P., Cerottini J.-C., Simon R., Zhao Y., Houghten R. A., Pinilla C., Valmori D., Combinatorial peptide library-based identification of peptide ligands for tumor-reactive cytolytic T lymphocytes of unknown specificity European Journal of Immunology 2002 32 8 2292 2299
118. Zhao Y., Gran B., Pinilla C., Markovic-Plese S., Hemmer B., Tzou A., Whitney L. W., Biddison W. E., Martin R., Simon R., Combinatorial peptide libraries and biometric score matrices permit the quantitative analysis of specific and degenerate interactions between clonotypic TCR and MHC peptide ligands Journal of Immunology 2001 167 4 2130 2141
119. Rammensee H.-G., Bachmann J., Emmerich N. P. N., Bachor O. A., Stevanovi S., SYFPEITHI: database for MHC ligands and peptide motifs Immunogenetics 1999 50 3-4 213 219
120. Pollack M. S., Livingston P. O., Fogh J., Genetically appropriate expression of HLA and DR (IA) alloantigens on human melanoma cell lines Tissue Antigens 1980 15 3 249 256
121. Wilson B. S., Indiveri F., Molinaro G. A., Characterization of DR antigens on cultured melanoma cells by using monoclonal antibodies Transplantation Proceedings 1980 12 1 125 129
122. Martins I., Sylla K., Deshayes F., Lauriol J., Ghislin S., Dieu-Nosjean M. C., Viguier M., Verola O., Charron D., Alcaide-Loridan C., Al-Daccak R., Coexpression of major histocompatibility complex class II with chemokines and nuclear NFkappaB p50 in melanoma: a rational for their association with poor prognosis Melanoma Research 2009 19 4 226 237
123. Heike M., Schlaak J., Schulze-Bergkamen H., Heyl S., Herr W., Schmitt U., Schneider P. M., Meyer Zum Bschenfelde K.-H., Specificities and functions of CD4+ HLA class II-restricted T cell clones against a human sarcoma: evidence for several recognized antigens Journal of Immunology 1996 156 6 2205 2213
124. Altomonte M., Pucillo C., Maio M., The overlooked 'nonclassical' functions of major histocompatibility complex (MHC) class II antigens in immune and nonimmune cells Journal of Cellular Physiology 1999 179 3 251 256